The Role of SIRT1 in Neuropathic Pain from the Viewpoint of Neuroimmunity.

The current clinical first-line treatment of neuropathic pain still considers only the nervous system as the target, and its therapeutic effect is limited. An increasing number of studies support the opinion that neuropathic pain is a result of the combined action of the sensory nervous system and the related immune system. Under physiological conditions, both the nervous system and the immune system can maintain homeostasis by adjusting the mitochondrial function when sensing noxious stimulation. However, in the case of neuropathic pain, mitochondrial regulatory dysfunction occurs, which may result from the decreased expression of SIRT1. In this study, we review the role of SIRT1 in neuropathic pain from the viewpoint of neuroimmunity. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Citation

Youjia Fan, Rong Dong, Honghai Zhang, Buwei Yu, Han Lu. The Role of SIRT1 in Neuropathic Pain from the Viewpoint of Neuroimmunity. Current pharmaceutical design. 2022;28(4):280-286

Mesh Tags

Substances

PMID: 34225609

search → result